Stock Events

Stock Events

Myriad Genetics 

$3.23
29
+$0.00+0% Thursday 20:00
-$0.01-0.31%Thursday 22:24After hours

Statistics

Day High
3.24
Day Low
3.22
52W High
8.59
52W Low
2.74
Volume
33,953
Avg. Volume
-
Mkt Cap
308.95M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

9NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.25
-0.15
-0.05
0.05
Expected EPS
-0.2125
Actual EPS
N/A

Financials

-44.38%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
824.5MRevenue
-365.9MNet Income

Analyst Ratings

3.33Average Price Target
The highest estimate is 4.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYGN. It's not an investment recommendation.
Alphabet
6
GOOGL
Apple
5
AAPL
Microsoft
5
MSFT
Amazon
5
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomic sequencing solutions and competes directly in the genetic testing market, overlapping with Myriad's cancer and other disease-related genetic tests.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies and cancer diagnostics, directly competing with Myriad's cancer genetic tests.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing services, competing with Myriad in the space of personalized medicine and genetic diagnostics.
Qiagen NV
QGEN
Mkt Cap8.9B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the genetic testing market.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics focuses on genomic analysis and offers services that compete with Myriad's genetic testing and analysis services.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete with Myriad's genetic testing technologies, especially in comprehensive genomic profiling.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a wide range of services and products for genetic analysis and diagnostics, competing with Myriad in the life sciences and healthcare sectors.
Quest Diagnostics
DGX
Mkt Cap26.79B
Quest Diagnostics provides diagnostic testing, information, and services, including genetic testing, competing with Myriad in the broader diagnostics market.

About

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Show more...
CEO
Samraat S Raha
Employees
2700
Country
United States
ISIN
US62855J1043
WKN
000897518

Listings

STU
DE
MYD.STU
MU
DE
MYD.MU
LSE
GB
0K3W.LSE
F
DE
MYD.F

0 Comments

Share your thoughts

FAQ

What is Myriad Genetics stock price today?▼
The current price of MYGN is $3.23 USD — it has increased by +0% in the past 24 hours. Watch Myriad Genetics stock price performance more closely on the chart.
What is Myriad Genetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Myriad Genetics stocks are traded under the ticker MYGN.
Is Myriad Genetics stock price growing?▼
MYGN stock has risen by +2.22% compared to the previous week, the month change is a +1.89% rise, over the last year Myriad Genetics has showed a -52.43% decrease.
What is Myriad Genetics market cap?▼
Today Myriad Genetics has the market capitalization of 308.95M
When is the next Myriad Genetics earnings date?▼
Myriad Genetics is going to release the next earnings report on November 09, 2026.
What were Myriad Genetics earnings last quarter?▼
MYGN earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.06 USD resulting in a -332.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Myriad Genetics revenue for the last year?▼
Myriad Genetics revenue for the last year amounts to 824.5M USD.
What is Myriad Genetics net income for the last year?▼
MYGN net income for the last year is -365.9M USD.
How many employees does Myriad Genetics have?▼
As of September 04, 2026, the company has 2,700 employees.
In which sector is Myriad Genetics located?▼
Myriad Genetics operates in the Health & Wellness sector.
When did Myriad Genetics complete a stock split?▼
The last stock split for Myriad Genetics was on March 26, 2009 with a ratio of 2:1.
Where is Myriad Genetics headquartered?▼
Myriad Genetics is headquartered in SALT LAKE CITY, United States.